Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | TSHR | P16473 | 5/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.35 |
| ▸ | CA9 | Q16790 | 3/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29601130 | 1.00 | — | — | |
| SCHEMBL1852390 | 1.00 | — | — | |
| SCHEMBL28612865 | 1.00 | ALDH1A1 (0.40) | ALDH1A1TSHRTDP1CA1CA9 | |
| SCHEMBL29457685 | 1.00 | ALDH1A1 (0.40) | ALDH1A1TSHRTDP1CA1CA9 | |
| Hydrochloric Acid SCHEMBL22471233 | 0.96 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1CA1CA9 | |
| Hydrochloric Acid SCHEMBL8521950 | 0.96 | — | — | |
| Benzene SCHEMBL28128746 | 0.96 | ALDH1A1 (0.43) | ALDH1A1TSHRTDP1CA1CA9 | |
| SCHEMBL49436 | 0.96 | — | — | |
| Bromide SCHEMBL10514507 | 0.92 | ALDH1A1 (0.40) | ALDH1A1TSHRTDP1CA1CA9 | |
| Water SCHEMBL22231695 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120071669-A1 | PROCESS FOR PREPARATION OF ELETRIPTAN AND SALT THEREOF | USV Limited B.S.D. Mar (IN) | 2012-03-22 | — | — | US | claimed |
| US-12545656-B2 | Organic light-emitting compound and organic electroluminescent device using the same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2026-02-10 | — | — | US | disclosed |
| US-11856806-B2 | Disubstituted dl aryloxybenzoh eterodi azole compounds | ENI S.P.A. (IT) | 2023-12-26 | — | — | US | disclosed |
| CN-111032642-B | Kinase inhibitors and methods of making and using the same | 里格尔药品股份有限公司 | 2023-07-18 | — | — | CN | disclosed |
| CN-112409315-B | Diamine monomer containing spirofluorene functional group, preparation method thereof and polyimide with low dielectric constant | 广东工业大学 | 2023-03-28 | — | — | CN | disclosed |
| EP-3867333-B1 | DISUBSTITUTED DIARYLOXYBENZOHETERODIAZOLE COMPOUNDS | ENI SPA (IT) | 2022-09-14 | — | — | EP | disclosed |
| US-11316117-B2 | Organometallic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-04-26 | — | — | US | disclosed |
| US-20210367176-A1 | DISUBSTITUTED DL ARYLOXYBENZOH ETERODI AZOLE COMPOUNDS | ENI S.P.A. (US) | 2021-11-25 | — | — | US | disclosed |
| CN-113166138-A | Disubstituted diaryloxybenzoheterodiazole compounds | 艾尼股份公司 | 2021-07-23 | — | — | CN | disclosed |
| CN-112409315-A | Diamine monomer containing spirofluorene functional group, preparation method thereof and polyimide with low dielectric constant | 广东工业大学 | 2021-02-26 | — | — | CN | disclosed |
| EP-1150937-A1 | LIQUID CRYSTALLINE TRIFLUORO-SUBSTITUTED COMPOUNDS | QinetiQ Limited (GB) | 2001-11-07 | — | — | EP | disclosed |
| EP-1144546-A2 | FLUORINATED TERPHENYLS | QinetiQ Limited (GB) | 2001-10-17 | — | — | EP | disclosed |
| WO-2000039062-A1 | LIQUID CRYSTALLINE TRIFLUORO-SUBSTITUTED COMPOUNDS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2000-07-06 | — | — | WO | disclosed |
| WO-2000004111-A2 | FLUORINATED TERPHENYLS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2000-01-27 | — | — | WO | disclosed |
| US-5763408-A | TUMOR METASTASIS INHIBITORS | FUJI PHOTO FILM CO., LTD. (JP) | 1998-06-09 | — | — | US | disclosed |
| EP-0821682-A1 | BENZIMIDAZOLE COMPOUNDS AND THEIR USE AS MODULATORS OF THE GABA A? RECEPTOR COMPLEX | NEUROSEARCH A/S (DK) | 1998-02-04 | — | — | EP | disclosed |
| WO-1996033191-A1 | BENZIMIDAZOLE COMPOUNDS AND THEIR USE AS MODULATORS OF THE GABAA RECEPTOR COMPLEX | NEUROSEARCH A/S (DK) | 1996-10-24 | — | — | WO | disclosed |
| EP-0644181-B1 | AMINO ACID DERIVATIVE AND USE THEREOF | FUJI PHOTO FILM CO LTD (JP) | 1996-09-04 | — | — | EP | disclosed |
| WO-1996019988-A1 | 4,4-(DISUBSTITUTED)CYCLOHEXAN-1-OLS MONOMERS AND RELATED COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-07-04 | — | — | WO | disclosed |
| EP-0644181-A1 | AMINO ACID DERIVATIVE AND USE THEREOF | FUJI PHOTO FILM CO., LTD. (JP) | 1995-03-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210367176-A1 | DISUBSTITUTED DL ARYLOXYBENZOH ETERODI AZOLE COMPOUNDS | CCND3, CCND2, CCND1 | ALDH1A1 936/4885TSHR 387/4885TDP1 4010/4885 |
| US-20120071669-A1 | PROCESS FOR PREPARATION OF ELETRIPTAN AND SALT THEREOF | HTR3C, SLC6A4, HTR3A | ALDH1A1 2989/4885TSHR 1370/4885TDP1 607/4885 |
| US-11856806-B2 | Disubstituted dl aryloxybenzoh eterodi azole compounds | LSS, CCND1, CCND2 | ALDH1A1 489/4885TSHR 3662/4885TDP1 4024/4885 |
| US-12545656-B2 | Organic light-emitting compound and organic electroluminescent device using the same | ELOVL1, EPB41L2, L1CAM | ALDH1A1 268/4885TSHR 2989/4885TDP1 1985/4885 |
| US-11316117-B2 | Organometallic compound and organic light-emitting device including the same | OCIAD1, L3MBTL1, OCIAD2 | ALDH1A1 817/4885TSHR 3243/4885TDP1 1054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.